In the News

FDA Clears Eko’s Heart Disease Detection AI for Adults and Pediatrics

Machine learning algorithm to assist healthcare professionals in identifying structural heart murmurs.
July 12, 2022

Eko, a digital health company advancing heart and lung disease detection, announced that the U.S. Food and Drug Administration (FDA) has cleared its Eko Murmur Analysis Software (EMAS) for detecting and characterizing murmurs found in adults and pediatric patients. The next generation of Eko’s murmur detection capabilities grants Eko the first and only smart stethoscope on the market that can identify and differentiate, between innocent and structural, heart murmurs indicative of valvular heart disease.

Read more at AI Thority